Clinical Trial Update: Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients [Phase 2]

View source ↗

Summary

This document reports an update on a Phase 2 clinical trial of SAT-3247 for Duchenne muscular dystrophy in pediatric ambulatory patients, which is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• SAT-3247

Snippet

Sponsor: Satellos Bioscience, Inc. | Conditions: Duchenne Muscular Dystrophy, Duchenne | Phase 2 | Status: RECRUITING